Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses
The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being challenged in court. The American Hospital Association, meanwhile, opposes the policy shift, saying it “errs by seeking to create a one-size-fits-all rule”
Why the business side of cardiology was a key focus at ACC.24
Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.
Major insurer partners with private equity firm for care coordination
Elevance said the move aims to expand patient access to primary care services for its Carelon Health patients.
Private equity bankruptcies in healthcare explode 112% in 5 years
According to the Private Equity Stakeholder Project, 21% of all healthcare bankruptcies in 2023 involved organizations owned by financial firms.
Cardiologist salary update: Compensation jumps to $525K per year, No. 3 among all specialties
In addition, cardiologists average an additional $75,000 per year in incentive-based bonuses. That number is only higher for two other specialties.

High costs limit the value of dapagliflozin, empagliflozin as heart failure treatments

SGLT2 inhibitors such as dapagliflozin and empagliflozin are associated with improved outcomes among many heart failure patients. The medications are not cost-effective, however, limiting their overall value. Read the full economic analysis to learn more.

March 8, 2023

During the 2022 State of the Union address, President Biden outlined a new plan to combat COVID-19 by testing and immediate treatment, plans to reduce drug costs, the need for more mental health coverage, and a call for more cancer research under an NIH program.

Biden’s budget: Extend Medicare solvency through higher taxes on rich, more drug price changes

Biden says his proposals are an extension of what he has already accomplished to reduce the deficit and lower healthcare spending.

March 7, 2023

MercyOne completes acquisition of Genesis

The deal was first announced in September 2022, and with its closure, all interests and operations of Genesis become part of MercyOne.

March 2, 2023

Eli Lilly caps insulin costs at $35 per month

The company announced price reductions of 70% for its most commonly prescribed insulins.

March 1, 2023

Medicare money payment physician. The CardioVascular Coalition and Society for Cardiovascular Angiography and Interventions have both issued new statements highlighting their issues with the 2024 MPFS proposed rule.

Hospitals still facing financial struggles in 2023

Hospital margins were -1% in January 2023, compared to -0.7% in December 2022.

February 28, 2023

When the American College of Cardiology and American Heart Association collaborated on new valvular heart disease (VHD) guidelines in 2020, the two groups highlighted the importance of interventional treatment options such as transcatheter aortic valve replacement (TAVR). However, an estimated one-third of patients with severe aortic stenosis (AS) in the U.S. still lack a guideline-recommended treatment plan, dramatically lowering their chances of survival. Doctor at computer

Hospital CEO turnover is on the rise

The number of CEO changes at U.S. companies rose 12% from December 2022 to January 2023, with hospital CEOs playing a key part in that trend.

February 28, 2023

Pfizer in talks to acquire Seagen in deal worth more than $30B

Pharmaceutical giant Pfizer is reportedly in talks to acquire Seagen, a biotechnology company focused on developing cancer therapies.

February 27, 2023

Humana to leave commercial insurance in favor of government programs

Humana plans to pull out of the commercial insurance space over the next 18 to 24 months.

February 23, 2023

Around the web

Cardiovascular Business

Cardiology groups share key update: ABMS seeking feedback on proposed Board of Cardiovascular Medicine

Five of the largest U.S. medical societies focused on cardiovascular health are one step closer to seeing their paradigm-shifting proposal become a reality.

Cardiovascular Business

Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses

The Society for Cardiovascular Angiography & Interventions and Society of Thoracic Surgeons have both shared statements in support of the ban, which is already being challenged in court. The American Hospital Association, meanwhile, opposes the policy shift, saying it “errs by seeking to create a one-size-fits-all rule”

Cardiovascular Business

Why the business side of cardiology was a key focus at ACC.24

Alison Bailey, MD, co-chair of the business of cardiology sessions at ACC.24, emphasized that reimbursement cuts can have a long-term negative impact on patient.

Economics

Cardiologists, thoracic surgeons applaud FTC’s ban of most noncompete clauses

Why the business side of cardiology was a key focus at ACC.24

Major insurer partners with private equity firm for care coordination

Private equity bankruptcies in healthcare explode 112% in 5 years

Cardiologist salary update: Compensation jumps to $525K per year, No. 3 among all specialties

Around the web